Latest Insider Transactions at First Real Estate Investment Trust Of New Jersey (FREVS)
This section provides a real-time view of insider transactions for First Real Estate Investment Trust Of New Jersey (FREVS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 20
2025
|
David F Mcbride Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+1.71%
|
-
|
Feb 20
2025
|
Justin Meng Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+1.69%
|
-
|
Feb 20
2025
|
John A Aiello Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+4.13%
|
-
|
Feb 20
2025
|
Ronald J Artinian Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+0.24%
|
-
|
Feb 20
2025
|
Richard Aslanian Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+2.15%
|
-
|
Feb 20
2025
|
David Hekemian Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+0.55%
|
-
|
Feb 20
2025
|
Robert S Hekemian Jr Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+0.54%
|
-
|
Oct 18
2024
|
Richard Aslanian Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+6.69%
|
$30,400
$8.0 P/Share
|
Sep 27
2024
|
David F Mcbride Director |
SELL
Open market or private sale
|
Direct |
3,000
-4.27%
|
$51,000
$17.04 P/Share
|
Sep 17
2024
|
David F Mcbride Director |
SELL
Open market or private sale
|
Direct |
6,000
-4.01%
|
$96,000
$16.99 P/Share
|
Sep 10
2024
|
Ronald J Artinian Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+0.2%
|
$7,000
$7.5 P/Share
|
Mar 22
2024
|
Justin Meng Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+1.77%
|
-
|
Mar 22
2024
|
Ronald J Artinian Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+0.25%
|
-
|
Mar 22
2024
|
Richard Aslanian Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+2.44%
|
-
|
Mar 22
2024
|
David Hekemian Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+0.57%
|
-
|
Mar 22
2024
|
Robert S Hekemian Jr Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+0.56%
|
-
|
Mar 22
2024
|
David F Mcbride Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+1.59%
|
-
|
Mar 22
2024
|
John A Aiello Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+4.43%
|
-
|
May 03
2023
|
David Hekemian Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+1.75%
|
$30,400
$8.0 P/Share
|
Apr 06
2023
|
Ronald J Artinian Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.2%
|
$7,000
$7.5 P/Share
|
Mar 09
2023
|
David Hekemian Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,290
+0.61%
|
-
|
Mar 09
2023
|
Robert S Hekemian Jr Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,290
+0.59%
|
-
|
Mar 09
2023
|
David F Mcbride Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,290
+1.69%
|
-
|
Mar 09
2023
|
Justin Meng Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,290
+1.89%
|
-
|
Mar 09
2023
|
John A Aiello Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
1,290
+4.85%
|
-
|
Mar 09
2023
|
Ronald J Artinian Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
1,290
+0.26%
|
-
|
Mar 09
2023
|
Richard Aslanian Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,290
+2.62%
|
-
|
Jan 27
2023
|
David Hekemian Director |
BUY
Other acquisition or disposition
|
Direct |
14,645
+6.56%
|
-
|
Jan 27
2023
|
Robert S Hekemian Jr Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
41,440
+16.12%
|
-
|
Jan 27
2023
|
David F Mcbride Director |
BUY
Other acquisition or disposition
|
Direct |
53,798
+42.16%
|
-
|
Jan 27
2023
|
Justin Meng Director |
BUY
Other acquisition or disposition
|
Direct |
33,950
+34.12%
|
-
|
Jan 27
2023
|
Ronald J Artinian Chairman of the Board |
BUY
Other acquisition or disposition
|
Direct |
72,775
+13.05%
|
-
|
Jan 27
2023
|
Richard Aslanian Director |
BUY
Other acquisition or disposition
|
Direct |
21,280
+31.31%
|
-
|
Nov 17
2022
|
David F Mcbride Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+48.72%
|
$190,000
$10.95 P/Share
|
Nov 01
2022
|
Ronald J Artinian Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
25,400
+2.96%
|
$228,600
$9.23 P/Share
|
Oct 27
2022
|
John A Aiello Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+44.19%
|
$247,000
$13.5 P/Share
|
Oct 26
2022
|
Robert S Hekemian Jr Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,000
+6.14%
|
$230,000
$10.95 P/Share
|
Oct 25
2022
|
David Hekemian Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,200
+7.51%
|
$271,800
$9.48 P/Share
|
Oct 19
2022
|
Allan Tubin Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+35.29%
|
$60,000
$10.95 P/Share
|
Oct 12
2022
|
Justin Meng Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+37.55%
|
$247,000
$13.5 P/Share
|
Oct 12
2022
|
Richard Aslanian Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,200
+37.44%
|
$121,600
$8.0 P/Share
|
Sep 29
2020
|
Ronald J Artinian Chairman of the Board |
BUY
Open market or private purchase
|
Indirect |
100
+2.25%
|
$1,400
$14.98 P/Share
|